193 related articles for article (PubMed ID: 26496339)
1. Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience.
Ferro M; De Cobelli O; Buonerba C; Di Lorenzo G; Capece M; Bruzzese D; Autorino R; Bottero D; Cioffi A; Matei DV; Caraglia M; Borghesi M; De Berardinis E; Busetto GM; Giovannone R; Lucarelli G; Ditonno P; Perdonà S; Bove P; Castaldo L; Hurle R; Musi G; Brescia A; Olivieri M; Cimmino A; Altieri V; Damiano R; Cantiello F; Serretta V; De Placido S; Mirone V; Sonpavde G; Terracciano D
Medicine (Baltimore); 2015 Oct; 94(42):e1861. PubMed ID: 26496339
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer.
Kimura S; D' Andrea D; Soria F; Foerster B; Abufaraj M; Vartolomei MD; Iwata T; Karakiewicz PI; Rink M; Gust KM; Egawa S; Shariat SF
Urol Oncol; 2019 Mar; 37(3):179.e19-179.e28. PubMed ID: 30580906
[TBL] [Abstract][Full Text] [Related]
3. Survival Outcome after Reduced-Port Laparoscopic Radical Cystectomy for Bladder Cancer: Long-Term Follow-Up Analysis.
Noda Y; Naiki T; Sugiyama Y; Nagai T; Naiki-Ito A; Kawai T; Hamamoto S; Etani T; Iida K; Tomiyama N; Aoki M; Shimizu N; Moritoki Y; Akita H; Ando R; Kawai N; Yasui T
Oncology; 2022; 100(8):429-438. PubMed ID: 35760062
[TBL] [Abstract][Full Text] [Related]
4. Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
Schuettfort VM; Gust K; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Enikeev D; Zimmermann K; Deuker M; Moschini M; Sari Motlagh R; Grossmann NC; Katayama S; Pradere B; Shariat SF
Minerva Urol Nephrol; 2022 Jun; 74(3):302-312. PubMed ID: 34114784
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
Qi F; Xu Y; Zheng Y; Li X; Gao Y
Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
[TBL] [Abstract][Full Text] [Related]
6. Oncological impact of inflammatory biomarkers in elderly patients treated with radical cystectomy for urothelial bladder cancer.
Mari A; Muto G; Di Maida F; Tellini R; Bossa R; Bisegna C; Campi R; Cocci A; Viola L; Grosso A; Scelzi S; Lapini A; Carini M; Minervini A
Arab J Urol; 2020 Aug; 19(1):2-8. PubMed ID: 33763243
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
[TBL] [Abstract][Full Text] [Related]
8. Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients.
Zhang ZL; Dong P; Li YH; Liu ZW; Yao K; Han H; Qin ZK; Zhou FJ
Chin J Cancer; 2014 Mar; 33(3):165-71. PubMed ID: 23958053
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer.
Soria F; Lucca I; Moschini M; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Rink M; Gust KM; Hassler MR; Foerster B; Abufarraj M; Haitel A; Klatte T; Shariat SF
Urol Oncol; 2017 Jun; 35(6):356-362. PubMed ID: 28342660
[TBL] [Abstract][Full Text] [Related]
11. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches.
Kim TH; Sung HH; Jeon HG; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC
J Endourol; 2016 Jul; 30(7):783-91. PubMed ID: 27055782
[TBL] [Abstract][Full Text] [Related]
12. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
[TBL] [Abstract][Full Text] [Related]
13. Modified Glasgow prognostic score can predict survival of muscle invasive bladder cancer patients after radiotherapy.
Kikuchi K; Nakamura R; Segawa T; Oikawa H; Ariga H
J Radiat Res; 2020 Jul; 61(4):616-621. PubMed ID: 32567660
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study.
Nouhaud FX; Chakroun M; Lenormand C; Ouzaid I; Peyronnet B; Gryn A; Prudhomme T; Grafeille V; Soulié M; Roumiguié M; Verhoest G; Xylinas E; Bouzouita A; Chebil M; Pfister C
Urol Oncol; 2021 Mar; 39(3):195.e1-195.e6. PubMed ID: 33214030
[TBL] [Abstract][Full Text] [Related]
15. Modified Glasgow Prognostic Score 2 as a Prognostic Marker in Patients With Metastatic Urothelial Carcinoma.
Nagai T; Naiki T; Isobe T; Sugiyama Y; Etani T; Iida K; Nozaki S; Noda Y; Shimizu N; Tasaki Y; Mimura Y; Banno R; Kubota H; Hamamoto S; Kawai N; Yasui T
In Vivo; 2021; 35(5):2793-2800. PubMed ID: 34410970
[TBL] [Abstract][Full Text] [Related]
16. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
Gschwend JE; Heck MM; Lehmann J; Rübben H; Albers P; Wolff JM; Frohneberg D; de Geeter P; Heidenreich A; Kälble T; Stöckle M; Schnöller T; Stenzl A; Müller M; Truss M; Roth S; Liehr UB; Leißner J; Bregenzer T; Retz M
Eur Urol; 2019 Apr; 75(4):604-611. PubMed ID: 30337060
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy.
Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
Urol Oncol; 2016 Jun; 34(6):257.e11-7. PubMed ID: 27038696
[TBL] [Abstract][Full Text] [Related]
18. The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer.
Djaladat H; Bruins HM; Miranda G; Cai J; Skinner EC; Daneshmand S
BJU Int; 2014 Jun; 113(6):887-93. PubMed ID: 23906037
[TBL] [Abstract][Full Text] [Related]
19. Robot Assisted Radical Cystectomy vs Open Radical Cystectomy: Over 10 years of the Mayo Clinic Experience.
Faraj KS; Abdul-Muhsin HM; Rose KM; Navaratnam AK; Patton MW; Eversman S; Singh R; Eversman WG; Cheney SM; Tyson MD; Castle EP
Urol Oncol; 2019 Dec; 37(12):862-869. PubMed ID: 31526651
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
